Ligand, Metabasis deal

Metabasis has a 2008 deal with Roche to apply the biotech's HepDirect liver-targeting technology to Roche's nucleosides to treat HCV. Ligand said its share of a cash milestone from Roche is expected to largely offset the cash payment for the acquisition in 2010. ...